All News

While it is still far from clear how specialists will adapt to the accountable care organization, and it seems likely that+M51 ACOs will take different shapes and forms, a sense of inevitability has settled in and urologists need to prepare themselves for change.

An underfilled schedule and increasing no-show rate are just two of the pitfalls to avoid.

Howard Goldman, MD, discusses the possible effects of FDA reclassification of transvaginal mesh used for prolapse as well as the importance of adequate surgical training and patient selection.

An implantable neurostimulator (InterStim, Medtronic, Minneapolis) improves voiding outcomes in patients with voiding dysfunction that is refractory to other therapies, a retrospective long-term follow-up of patients at a single center showed.

The recently published meaningful use Stage 2 final rule will directly affect urology practices.

Urologists share some simple methods and techniques that make their job easier.

Osteoporosis, pelvic organ prolapse, and incontinence are common in postmenopausal women and may share a common pathway, a recent study suggests.

Results of a recent study support the use of barbed polyglyconate sutures to facilitate vesicourethral anastomosis (VUA) during robot-assisted radical prostatectomy.

A biopsy-based genomic assay that would discriminate between aggressive prostate cancer and indolent disease to guide treatment decisions is under development.

Rendering stone fragments paramagnetic by exposure to iron oxide-based microparticles shows promise as a novel approach for reducing the number of small retained fragments after ureteroscopic lithotripsy, say researchers who are developing the technology.

The RANK ligand inhibitor denosumab (XGEVA) may be able to prevent or at least delay multiple and/or symptomatic bone metastases in men with castration-resistant prostate cancer (CRPC) at high risk of bone metastases.

Functional recovery after partial nephrectomy correlated more closely with volume loss than with warm ischemia time, researchers from Cleveland Clinic's Glickman Urological and Kidney Institute recently reported.

A study from Duke University, Durham, NC suggests that folic acid may reduce the risk of prostate cancer recurrence following radical prostatectomy.

Controversies related to circumcision could lead to a rise in medical liability for urologists performing this procedure, writes the American Association of Clinical Urologists' Tim Lytle.

The difference in prostate cancer mortality among men with low-risk disease who choose active surveillance versus those who choose immediate treatment with radical prostatectomy is likely to be very modest—possibly as little as 2 to 3 months—a new research model has estimated.

Individuals with at least one symptomatic kidney stone episode have significantly heightened risks of end-stage renal disease (ESRD), chronic kidney disease, and sustained doubling of serum creatinine concentration, according to the results of a Canadian study.

New guidelines from the University of Michigan Health System, Ann Arbor, offer family physicians a step-by-step guide for the evaluation of urinary incontinence.

The FDA has approved the production and use of Choline C 11 Injection, a positron emission tomography agent used to help detect recurrent prostate cancer.

The 2012 Arthur D. Smith Endourology Lectureship has been awarded to Mihir Mahesh Desai, MD, DNB, director of the Center for Advanced Robotics at the University of Southern California Institute of Urology, Los Angeles.

The American Board of Urology (ABU) has joined several other member boards of the American Board of Medical Specialties (ABMS) in reporting publicly whether its physicians are meeting ABMS maintenance of certification requirements.

Researchers from the University of Southern California, Los Angeles have found a link between recreational marijuana use and an increased risk of developing subtypes of testicular cancer that tend to carry a worse prognosis.

The American Society for Radiation Oncology has submitted a letter to the Centers for Medicare & Medicaid Services opposing proposed policy changes for calendar year 2013 that would cut nearly $300 million for cancer treatment.

Taking aspirin is associated with a lower risk of death from prostate cancer, especially in men with high-risk disease, according to a recent multicenter study.

Academic Urology, a large urology group practice in eastern Pennsylvania, has signed a new 3-year contract with Independence Blue Cross (IBC) and is currently participating in IBC’s network.

A 2008 Medicare policy to stop payment for preventable, hospital-acquired conditions such as post-catheterization urinary tract infections has led to very little change in hospital payment, say researchers from the University of Michigan, Ann Arbor.

Prostate cancer in African-American men appears to be associated with specific changes in the IL-16 gene, according to researchers at the University of Illinois at Chicago College of Medicine.

A procedure designed to streamline robotic partial nephrectomy significantly reduces warm ischemia time (WIT) by nearly 25%, according to a recent analysis.